Imisopasem manganese

DB04976InvestigationalProtein Based Therapies

M40403 is a low molecular weight, synthetic manganese containing superoxide dismutase mimetic (SODm) that selectively removes superoxide anion.

Mechanism
Curator reviewed
Primary indication
Intended for the treatment of pain and possibly various forms of cancer.Curator reviewed
Also known as
M40403

Resolves to

Targets

What you can answer from here — as of April 02, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
10+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Imisopasem manganese, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account